New Screening Methods in Melanoma
Author Information
Author(s): Czerw Aleksandra, Deptała Andrzej, Partyka Olga, Pajewska Monika, Badowska-Kozakiewicz Anna, Budzik Michał, Sygit Katarzyna, Kopczyński Zygmunt, Czarnywojtek Piotr, Cipora Elżbieta, Konieczny Magdalena, Banaś Tomasz, Grochans Elżbieta, Grochans Szymon, Cybulska Anna Maria, Schneider-Matyka Daria, Bandurska Ewa, Ciećko Weronika, Drobnik Jarosław, Pobrotyn Piotr, Grata-Borkowska Urszula, Furtak-Pobrotyn Joanna, Sierocka Aleksandra, Marczak Michał, Kozlowski Remigiusz
Primary Institution: Medical University of Warsaw
Hypothesis
This study aims to show current trends in clinical trials for melanoma screening.
Conclusion
Intensification of behavioural interventions and health promotion activities is recommended.
Supporting Evidence
- Melanoma is an aggressive type of skin cancer that is preventable and treatable if detected early.
- The World Health Organisation reported 331,722 melanoma cases worldwide in 2022.
- 20% of studies on melanoma screening research advanced imaging techniques using machine learning.
- 16% of studies explore behavioral interventions for melanoma prevention.
- Most European countries have a high likelihood of five-year survival for melanoma, typically ranging from 80% to 90%.
Takeaway
Melanoma is a serious skin cancer, but if caught early, it can be treated. This study looks at new ways to find melanoma early.
Methodology
The analysis was conducted using data from clinicaltrials.gov, focusing on interventional and observational studies on melanoma screening.
Potential Biases
The study may not adequately represent younger populations and relies on existing clinical trial data.
Limitations
Most studies focus on adult patients at risk, with only one study targeting younger individuals.
Participant Demographics
The majority of studies included adult participants, with one study focusing on women aged 18-40.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website